Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024)
Powered by 
Analysis
Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Verastem | 815.85 Mn | 679.49 Mn | 36.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -66.67% |
| Sep 30, 2020 | 1,257.14% |
| Jun 30, 2020 | 7.69% |
| Dec 31, 2018 | -53.62% |
| Sep 30, 2018 | 11.61% |
| Jun 30, 2018 | 200.59% |
| Dec 31, 2015 | -12.50% |
| Mar 31, 2015 | -65.43% |
| Dec 31, 2014 | -60.90% |
| Sep 30, 2014 | 260.70% |
| Jun 30, 2014 | 3,920.00% |
| Mar 31, 2014 | -50.00% |
| Dec 31, 2013 | 300.00% |
| Dec 31, 2012 | -107.14% |
| Sep 30, 2012 | 316.22% |
| Jun 30, 2012 | -71.54% |
| Mar 31, 2012 | 319.35% |
| Dec 31, 2011 | -91.60% |